Open AccessA Narrative Review of Where We Are With Point-of-Care Sexually Transmitted Infection Testing in the United States
Author(s) -
Charlotte A. Gaydos,
Yukari C. Manabe,
Johan H. Melendez
Publication year - 2021
Publication title -
sexually transmitted diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.507
H-Index - 105
eISSN - 1537-4521
pISSN - 0148-5717
DOI - 10.1097/olq.0000000000001457
Subject(s) - medicine , point of care testing , syphilis , gonorrhea , food and drug administration , clearance , chlamydia , diagnostic test , point of care , nucleic acid amplification tests , intensive care medicine , medical physics , gynecology , family medicine , human immunodeficiency virus (hiv) , pediatrics , medical emergency , immunology , pathology , chlamydia trachomatis , urology
Point-of-care (POC) tests enable immediate diagnosis and targeted treatment of sexually transmitted infections (STIs), which could accelerate control of ongoing epidemics. Although older nucleic acid amplification tests have improved the accuracy of laboratory-based tests for STIs, newer POC tests can facilitate control efforts. We sought to review the performance and time to result of POC assays for STIs in the last 10 years.